- Are Synvisc and Monovisc the Same Thing?
- What Are Possible Side Effects of Monovisc?
- What Are Possible Side Effects of Synvisc?
- What is Monovisc?
- What is Synvisc?
- What Drugs Interact with Monovisc?
- What Drugs Interact with Synvisc?
- How Should Monovisc Be Taken?
- How Should Synvisc Be Taken?
Are Monovisc and Synvisc the Same Thing?
Monovisc (high molecular weight hyaluronan injection) and Synvisc (hylan G-F 20) are viscosupplements used to treat pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics.
What Are Possible Side Effects of Monovisc?
Common side effects of Monovisc include:
- joint pain and swelling,
- injection site reactions,
- rash,
- headache,
- dizziness,
- chills,
- hives,
- itching,
- nausea,
- muscle cramps,
- swelling of legs and feet, and
- a general feeling of being unwell (malaise)
What Are Possible Side Effects of Synvisc?
Common side effects of Synvisc include:
- injection site reactions (pain, swelling, warmth, stiffness, puffiness, or fluid buildup in or around the knee),
- muscle pain,
- trouble walking,
- fever,
- chills,
- nausea,
- numbness or tingly feeling,
- headache,
- dizziness,
- tired feeling, or
- itching or skin irritation around the knee.
Tell your doctor if you have serious side effects of Synvisc including:
- back pain,
- severe headache, or
- fast or pounding heartbeat.
What is Monovisc?
Monovisc (high molecular weight hyaluronan injection) is a complex sugar used to treat pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen).
What is Synvisc?
Synvisc (hylan G-F 20) is a type of osteoarthritis knee pain treatment called a viscosupplement or hyaluronan injection prescribed for treatment of osteoarthritis of the knee in patients who have failed to respond to simple analgesics.
How Should Monovisc Be Taken?
Monovisc is supplied in a single-use 5 mL syringe containing a 4 mL dose of treatment.
How Should Synvisc Be Taken?
Synvisc is administered in 3 injections in a doctor's office, done one week apart to provide relief of osteoarthritis knee pain for up to 6 months.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.